James C Momtazee is of Roivant Sciences Ltd.. Currently has a direct ownership of 109,030 shares of ROIV, which is worth approximately $2.21 Million. The most recent transaction as insider was on Oct 31, 2022, when has been sold 3,404 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 109K
0.45% 3M change
15.25% 12M change
Total Value Held $2.21 Million

JAMES C MOMTAZEE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 31 2022
BUY
Grant, award, or other acquisition
-
3,404 Added 5.61%
57,327 Common Shares
Oct 16 2022
BUY
Grant, award, or other acquisition
-
1,594 Added 2.07%
75,456 Common Shares
Sep 15 2022
BUY
Grant, award, or other acquisition
-
50,000 Added 48.11%
53,923 Common Shares
Jul 20 2022
BUY
Grant, award, or other acquisition
-
3,923 Added 50.0%
3,923 Common Shares

Also insider at

BBIO
BridgeBio Pharma, Inc. Healthcare
JCM

James C Momtazee

London, X0

Track Institutional and Insider Activities on ROIV

Follow Roivant Sciences Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ROIV shares.

Notify only if

Insider Trading

Get notified when an Roivant Sciences Ltd. insider buys or sells ROIV shares.

Notify only if

News

Receive news related to Roivant Sciences Ltd.

Track Activities on ROIV